GERMANTOWN, Md., October 04, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan (the "Plan") in accordance with NYSE American Company Guide Section 711(a).
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44 million. Aprea Therapeutics, Inc. (NASDAQ: APRE) rose 15.1% to $5.58 in pre-market trading after the company announced it presented data from the Phase 1/2 trial of eprenetapopt in advanced solid tumors at ESMO Congress 2021. American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) rose 14.1% to $3.23 in pre-market tradin